CHEMICAL NAME
1-{N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl} -L-proline maleate
FORMULA
C20H28N2O5.C4H4O4
DESCRIPTION
White to off-white, crystalline powder.
SPECIFICATIONS
The product meets USP and Ph. Eur. requirements.
PHARMACOLOGICAL PROPERTIES
Enalapril maleate is the maleate salt of enalapril, a derivative of two aminoacids, L-
alanine and L-proline. It belongs to the group of angiotensin-converting enzyme inhibitors
(ACE inhibitors). Inhibition of ACE results in decreased plasma angiotensin II, increased
plasma renin activity (removal of negative feedback on renin) and in decreased
aldosterone secretion. The antihypertensive effect of enalapril maleate results primarily
from suppression of the renin-angiotensin-aldosterone system which plays the principal
role in regulation of blood pressure, although enalapril maleate is antihypertensive even
in patients with low-renin hypertension.
USES
Enalapril maleate is used for the treatment of hypertension or heart failure. It is also
used for the prevention of development of heart failure. In many patients with symptoms
of heart failure enalapril maleate delays deterioration of the condition, decreases the
incidence of hospitalization for heart failure, improves survival and quality of life.
INDICATIONS
PRESENTATION
Double polyethylene bags inserted in multi-layer bags in drums.
Product protected by patent in a country are not offered or supplied to that country.
CORPORATION
Company overview | Lek Worldwide | Media Room | Employment Opportunities | Research and Development | Environmental Protection | Business Partners
HEALTH
Prescription Drugs | OTC Products | Active Pharmaceutical Ingredients
© LEK d.d. 1998-2008 / Legal notices